|
1
|
Davignon J and Ganz P: Role of endothelial
dysfunction in atherosclerosis. Circulation. 109:27–32. 2004.
View Article : Google Scholar
|
|
2
|
Yoder MC: Human endothelial progenitor
cells. Cold Spring Harbor Perspect Med. 2:a0066922012. View Article : Google Scholar
|
|
3
|
Chhabra N: Endothelial dysfunction-A
predictor of atherosclerosis. Inter J Med Update. 4:33–41.
2009.
|
|
4
|
Park KH and Park WJ: Endothelial
dysfunction: Clinical implications in cardiovascular disease and
therapeutic approaches. J Korean Med Sci. 30:1213–1225. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rajendran P, Rengarajan T, Thangavel J,
Nishigaki Y, Sakthisekaran D, Sethi G and Nishigaki I: The vascular
endothelium and human diseases. Int J Biol Sci. 9:1057–1069. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Werner N, Junk S, Laufs U, Link A, Walenta
K, Bohm M and Nickenig G: Intravenous transfusion of endothelial
progenitor cells reduces neointima formation after vascular injury.
Circ Res. 93:e17–e24. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang PH, Chen YH, Chen YL, Wu TC, Chen JW
and Lin SJ: Vascular endothelial function and circulating
endothelial progenitor cells in patients with cardiac syndrome X.
Heart. 93:1064–1070. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin JM, Zhao JY, Zhuang QC, Hong ZF and
Peng J: Xiongshao capsule promotes angiogenesis of HUVEC via
enhancing cell proliferation and up-regulating the expression of
bFGF and VEGF. Chin J Integr Med. 17:840–846. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Carratelli CR, Paolillo R and Rizzo A:
Chlamydia pneumoniae stimulates the proliferation of HUVEC through
the induction of VEGF by THP-1. Int Immunopharmacol. 7:287–294.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hassel D, Cheng P, White MP, Ivey KN,
Kroll J, Augustin HG, Katus HA, Stainier DY and Srivastava D:
MicroRNA-10 regulates the angiogenic behavior of zebrafish and
human endothelial cells by promoting vascular endothelial growth
factor signaling. Circ Res. 111:1421–1433. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu X, Song X, Yuan T, He J, Wang X and
Wang Q: Effects of calpain on sevoflurane-induced aged rats
hippocampal neuronal apoptosis. Aging Clin Exp Res. 28:633–639.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hofstetter C, Boost KA, Flondor M,
Basagan-Mogol E, Betz C, Homann M, Muhl H, Pfeilschifter J and
Zwissler B: Anti-inflammatory effects of sevoflurane and mild
hypothermia in endotoxemic rats. Acta Anaesthesiol Scand.
51:893–899. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Herrmann IK, Castellon M, Schwartz DE,
Hasler M, Urner M, Hu G, Minshall RD and Beck-Schimmer B: Volatile
anesthetics improve survival after cecal ligation and puncture.
Anesthesiology. 119:901–906. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Julier K, da Silva R, Garcia C, Bestmann
L, Frascarolo P, Zollinger A, Chassot PG, Schmid ER, Turina MI, von
Segesser LK, et al: Preconditioning by sevoflurane decreases
biochemical markers for myocardial and renal dysfunction in
coronary artery bypass graft surgery: A double-blinded,
placebo-controlled, multicenter study. Anesthesiology.
98:1315–1327. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun SX, Ge BX and Miao CH: Effects of
preconditioning with sevoflurane on TNF-α-induced permeability and
activation of p38 MAPK in rat pulmonary microvascular endothelial
cells. Cell Biochem Biophys. 61:123–129. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ebert TJ, Harkin CP and Muzi M:
Cardiovascular responses to sevoflurane: A review. Anesth Analg. 81
(Suppl 6):S11–S22. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vlad AM, Isvoranu G, Gilca M, Ceafalan L,
Surcel M, Stoian I and Manda G: Sevoflurane increases
proliferation, adhesion on HUVEC and incorporation in tubular
structures of endothelial progenitor cells. FASEB J.
29:LB5902015.
|
|
18
|
Yang Y, Hu R, Yan J, Chen Z, Lu Y, Jiang J
and Jiang H: Sevoflurane inhibits the malignant potential of head
and neck squamous cell carcinoma via activating the
hypoxiainducible factor-1α signaling pathway in vitro. Int J Mol
Med. 41:995–1002. 2018.PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Saffi MA, Furtado MV, Polanczyk CA,
Montenegro MM, Ribeiro IW, Kampits C, Haas AN, Rösing CK and
Rabelo-Silva ER: Relationship between vascular endothelium and
periodontal disease in atherosclerotic lesions: Review article.
World J Cardiol. 7:26–30. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Meguro K, Iidaka T, Nakata M, Yamashita T,
Chinen T, Fujita M, Kikuchi T, Keida T and Ohira H: Regular
exercise habits and vascular endothelium function in patients with
cardiovascular diseases. Eur Heart J. 35:730–731. 2014.
|
|
22
|
Gerber HP, Vu TH, Ryan AM, Kowalski J,
Werb Z and Ferrara N: VEGF couples hypertrophic cartilage
remodeling, ossification and angiogenesis during endochondral bone
formation. Nat Med. 5:623–628. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dzietko M, Derugin N, Wendland MF, Vexler
ZS and Ferriero DM: Delayed VEGF treatment enhances angiogenesis
and recovery after neonatal focal rodent stroke. Transl Stroke Res.
4:189–200. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lopes RA, Neves KB, Tostes RC, Montezano
AC and Touyz RM: Downregulation of nuclear factor Erythroid
2-related factor and associated antioxidant genes contributes to
redox-sensitive vascular dysfunction in hypertension. Hypertension.
66:1240–1250. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Neves KB, Rios FJ, van der Mey L,
Alves-Lopes R, Cameron AC, Volpe M, Montezano AC, Savoia C and
Touyz RM: VEGFR (Vascular Endothelial Growth Factor Receptor)
inhibition induces cardiovascular damage via redox-sensitive
processes. Hypertension. 71:638–647. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ferrara N, Carver-Moore K, Chen H, Dowd M,
Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ and Moore MW:
Heterozygous embryonic lethality induced by targeted inactivation
of the VEGF gene. Nature. 380:439–442. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Carmeliet P, Ferreira V, Breier G,
Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A,
Harpal K, Eberhardt C, et al: Abnormal blood vessel development and
lethality in embryos lacking a single VEGF allele. Nature.
380:435–439. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Takahashi H and Shibuya M: The vascular
endothelial growth factor (VEGF)/VEGF receptor system and its role
under physiological and pathological conditions. Clin Sci (Lond).
109:227–241. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fong GH, Rossant J, Gertsenstein M and
Breitman ML: Role of the Flt-1 receptor tyrosine kinase in
regulating the assembly of vascular endothelium. Nature. 376:66–70.
1995. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Roberts DM, Kearney JB, Johnson JH,
Rosenberg MP, Kumar R and Bautch VL: The vascular endothelial
growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1
(VEGFR-2) signaling during blood vessel formation. Am J Pathol.
164:1531–1535. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jiang JX, Chen XL, Serizawa N,
Szyndralewiez C, Page P, Schröder K, Brandes RP, Devaraj S and
Török NJ: Liver fibrosis and hepatocyte apoptosis are attenuated by
GKT137831, a novel NOX4/NOX1 inhibitor in vivo. Free Radic Biol
Med. 53:289–296. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shalaby F, Rossant J, Yamaguchi TP,
Gertsenstein M, Wu XF, Breitman ML and Schuh AC: Failure of
blood-island formation and vasculogenesis in Flk-1-deficient mice.
Nature. 376:62–66. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ranayhossaini DJ, Rodriguez AI, Sahoo S,
Chen BB, Mallampalli RK, Kelley EE, Csanyi G, Gladwin MT, Romero G
and Pagano PJ: Selective Recapitulation of conserved and
Nonconserved regions of putative NOXA1 protein activation domain
confers isoform-specific inhibition of Nox1 oxidase and attenuation
of endothelial cell migration. J Biol Chem. 288:36437–36450. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Makinen T, Jussila L, Veikkola T, Karpanen
T, Kettunen MI, Pulkkanen KJ, Kauppinen R, Jackson DG, Kubo H,
Nishikawa S, et al: Inhibition of lymphangiogenesis with resulting
lymphedema in transgenic mice expressing soluble VEGF receptor-3.
Nat Med. 7:199–205. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hogan BM, Herpers R, Witte M, Heloterä H,
Alitalo K, Duckers HJ and Schulte-Merker S: Vegfc/Flt4 signalling
is suppressed by Dll4 in developing zebrafish intersegmental
arteries. Development. 136:4001–4009. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Park JA, Kim DY, Kim YM, Lee IK and Kwon
YG: Endothelial snail regulates capillary branching morphogenesis
via vascular endothelial growth factor receptor 3 expression. PLoS
Genet. 11:e10053242015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Clarkin CE and Gerstenfeld LC: VEGF and
bone cell signalling: An essential vessel for communication? Cell
Biochem Funct. 31:1–11. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Moslehi JJ: Cardiovascular toxic effects
of targeted cancer therapies. New Engl J Med. 375:1457–1467. 2016.
View Article : Google Scholar : PubMed/NCBI
|
